- Training
- 60 Minutes
Global
- Report
- September 2023
- 100 Pages
Global
From €5299EUR$5,950USD£4,591GBP
- Report
- March 2025
- 107 Pages
China
From €1603EUR$1,800USD£1,389GBP
- Report
- March 2025
- 251 Pages
China
From €3562EUR$4,000USD£3,086GBP
- Report
- August 2024
- 272 Pages
China
From €3562EUR$4,000USD£3,086GBP
- Report
- August 2024
- 101 Pages
China
From €1603EUR$1,800USD£1,389GBP
- Report
- August 2024
- 88 Pages
China
From €1603EUR$1,800USD£1,389GBP
- Report
- August 2024
- 88 Pages
China
From €1603EUR$1,800USD£1,389GBP
- Report
- July 2025
- 387 Pages
Europe
From €956EUR$1,111USD£800GBP
- Report
- December 2022
- 69 Pages
Global
From €1781EUR$2,000USD£1,543GBP
- Report
- December 2022
- 99 Pages
Global
From €1781EUR$2,000USD£1,543GBP
- Report
- October 2022
- 90 Pages
Global
From €1781EUR$2,000USD£1,543GBP
- Report
- May 2022
- 47 Pages
Global
From €1781EUR$2,000USD£1,543GBP
- Report
- May 2022
- 226 Pages
Global
From €2226EUR$2,500USD£1,929GBP
- Report
- May 2022
- 84 Pages
Global
From €1781EUR$2,000USD£1,543GBP
- Report
- October 2024
- 96 Pages
Global
From €3500EUR$4,210USD£3,139GBP
- Book
- October 2023
- 400 Pages
- Book
- February 2022
- 400 Pages
- Book
- October 2021
- 400 Pages
- Book
- May 2023
- 178 Pages

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more